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Abstract
Motivation: Microarray data has been recently been shown to be efficacious in distinguishing closely
related cell types that often appear in the diagnosis of cancer. It is useful to determine the minimum
number of genes needed to do such a diagnosis both for clinical use and to determine the importance of
specific genes for cancer. Here a replication algorithm is used for this purpose. It evolves an ensemble of
predictors, all using different combinations of genes to generate a set of optimal predictors.
Results: We apply this method to the leukemia data of the Whitehead/MIT group that attempts to
differentially diagnose two kinds of leukemia, and also to data of Khan et. al. to distinguish four different
kinds of childhood cancers. In the latter case we were able to reduce the number of genes needed from
96 down to 15, while at the same time being able to perfectly classify all of their test data.
Availability: http://stravinsky.ucsc.edu/josh/gesses/
Contact: josh@physics.ucsc.edu
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2Introduction
cDNA microarrays have been used with great success to distinguish cell types from each other, and hence
has promising applications to cancer diagnosis. While the histopathology of two cells may appear very
similar, their clinical behavior, such as their response to drugs can be drastically different. The use of
microarrays has been shown in many cases to provide clear differential diagnosis rivaling or surpassing
other methods and leads to a clustering of data into different forms of a disease(DeRisi et al., 1996; Alon
et al., 1999; Perou et al., 1999; Zhu et al., 1998; Wang et al., 1999; Schummer et al., 1999; Zhang et al.,
1997; Alizadeh et al., 2000; Golub et al., 1999; Khan et al., 2001).
Many approaches have been used to classify microarray data. These include the use of artificial
neural networks(Khan et al., 2001; Furey et al., 2000), logistic regression(Li & Yang, 2001), support
vector machines(Brown et al., 2000; Furey et al., 2000), coupled two-way clustering(Getz et al., 2000),
and weighted votes - neighborhood analysis(Golub et al., 1999). For much of the data all these techniques
appear to give similar results and their performance improves as the amount and quality of data increases.
For example work on the classification of two different leukemias(Golub et al., 1999) attempts to classify
34 test samples based on 38 training samples. On prediction of test data, different predictors make
anywhere from 0 to 5 mistakes. On the other hand, recent work on small round blue cell tumors
(SRBCT) attempted to classify 20 test samples based on 63 training samples(Khan et al., 2001). They
were able to classify all test data correctly into one of four separate categories. They were able to do this
with a single layer neural network that considered only 96 genes.
To classify samples using microarray data, it is necessary to decide which genes should be included
in a predictor. Including too few genes will not discriminate in a detailed enough manner to classify test
data correctly. Having too many genes is not optimal either, as many of the genes are largely irrelevant
to the diagnosis and mostly have the effect of adding noise, decreasing the “information criterion”(Li &
Yang, 2001; Akaike, 1974; KP Burnham, 1998; Schwarz, 1976). This is particularly severe with a noisy
data set and few subjects. Therefore an effort is made to choose an optimal set of genes for which to start
the training of a predictor. This is done in a variety of different ways, such as a kind of neighborhood
analysis(Golub et al., 1999), principle component analysis(Khan et al., 2001), or gene shaving(Hastie
et al., 2000) A predictor can then be developed from this carefully chosen subset of genes.
Recent work(Li & Yang, 2001) addressed the problem of gene selection for a leukemia data set(Golub
et al., 1999). They initially ranked genes as had been done in the first analysis(Golub et al., 1999) and
used the top ranked genes. They varied the number they included and found no clear indication of any
optimum number aside from the conclusion that the number should be much smaller than the 50 that
had been originally used(Golub et al., 1999).
Here we develop gene selection further by making it an integral part of the prediction algorithm
itself. Instead of using all of the highest ranked genes, we find an effective method to greatly reduce this
number. This can be done because gene expression tends to be highly correlated, making many of the
3initially chosen genes redundant or even deleterious because of the problem of added noise.
The method introduced here is named GESSES (genetic evolution of sub-sets of expressed sequences).
It makes use of a kind of evolutionary algorithm known as a replication algorithm that has been exten-
sively used in quantum simulations (Ceperley & Kalos, 1979) and protein folding(Garel & Orland, 1990).
It finds a set of highly relevant genes by considering a whole ensemble of predictors, each of which use a
different sets of genes. As the predictors evolve, more genes are added to each predictor. It eventually
produces an ensemble of predictors each of which can be tried on test data.
In the case of small round blue cell tumors, GESSES reduces the number of genes from 96 down to
below 15 while still predicting the test data perfectly.
Aside from optimizing predictive capabilities, it is hoped that GESSES will have applications in the
clinical diagnosis of cancer(He & Friend, 2001). For this purpose it is important to use as few genes as
possible and still obtain an accurate diagnosis of the disease.
With the same algorithms applied to leukemia data of Golub et. al., we find conclusions in accord
with Li and Yang(Li & Yang, 2001) that there is no clear indication of an optimum number of genes
to use in a predictor. We find a range of predictors some that predict the test data perfectly but many
predictors that get several samples wrong. This is also in accord with other groups work(Golub et al.,
1999; Furey et al., 2000). Without further data or further biological information, it is probably not
possible to do better than this. This paper is organized as follows. We discuss the algorithm used in
detail by first defining the terminology and concepts used. Then we discuss the predictor used, the kind
of evolutionary algorithms and the scoring function. We then apply this to two data sets, the SRBCT
and leukemia data. Last, we make some concluding remarks.
The Algorithm
Terminology
We have samples of microarray training data Dt ≡ {D1, D2, . . .} with each sample consisting of N genes.
Corresponding to the ith gene of a sample is its expression level ei. The complete set of genes Gt is the
collection of genes 1 through N and we will consider subsets of Gt, for example the subset α1, α2, . . . , αm.
(e.g. genes 2,5, and 9), which we denote Gα. For this subspace of genes the vector of expression levels
eα ≡ (eα1 , . . . , eαm) . The number m of genes in this subset is denoted |α|, which in this case is m.
Each sample D has a classification of type T , in this case the type of cancer, which can take one of
NT values. The set of possible types is denoted T .
We introduce the usual definition of the Euclidean distance between samples Da and Db on the
subspace Gα:
d2α(a, b) =
1
|α|
|eaα − e
b
α|
2 =
1
|α|
|α|∑
i=1
|eaαi − e
b
αi |
2 (1)
4where eaα and e
b
α are the expression levels of samples a and b respectively, for genes α1, α2, . . . , αm.
Predictor
We define a predictor P as a function that takes a data sample D and outputs a type T , in this case the
type of cancer that is associated with that data. That is P(D)→ T .
In this work we will use a k-nearest neighbor search(Duda & Hart, 1973) to construct the predictor.
In the results reported below, we use k = 1, that is, the set of samples that forms the training data
Dt are compared with the target sample D by finding the distance using eqn. (1) between D and each
vector in the training set. The sample in the training set closest to D gives the classification T of D. The
distance depends on what subspace of genes G is used hence the predictor depends both on the training
data and G. Sometimes we will explicitly denote this dependence by writing the predictor as PG.
We will use variants of this basic predictor when constructing a scoring function that we discuss
below. For this we will not only need the closest point, but the values of the distances to all sample
points.
Evolution Algorithms
Starting off with an ensemble of different gene subspaces we want to determine rules to evolve it to a new
one that gives a better set of predictors. To do this, we have to have a measure of how well a predictor
classifies samples into separate types. We do this by means of a scoring function.
Scoring function
The scoring function is used to determine how well the predictor predicts data. By definition we cannot
use any information from the independent test data in the development of the predictors. Therefore we
consider only the training data Dt to determine the fitness of a predictor. In other words, we need to
score the effectiveness of the predictor using only Dt. This is done as follows.
1. We consider one point Dp in Dt as a pseudo test data point, and eliminate this point from Dt,
calling the resultant training data D′t. We then loop over all points in Dp ∈ Dt in the following
steps.
(a) We find the set of distances between Dp and points in D
′
t.
(b) If the type of the point giving the shortest distance matches the type of Dp, we add 1 to the
scoring function. Otherwise we add nothing and skip the remaining steps, continuing to loop
over the remaining Dp’s.
(c) We consider the distances grouped by the classification type of the target points. We consider
the shortest distance of each type from Dp, whch we call d1, d2, . . . , dNT .
5(d) Of these we take the two shortest, di and dj and add C|d
2
i − d
2
j | where C is a constant chosen
so that the value of this added term is ≪ 1.
The scoring function depends on the predictor, which in turn is determined by the training data and
the subspace of genes G. We will denote this latter dependence as SG
Initial Gene Pool
Often it is necessary to narrow down the genes that are considered from the many thousand that are
measured on the microarray down to of order 102 that are most relevant. There are many ways of doing
this, one common method being principle component analysis. For the purposes here we choose instead
a different method that is highly effective.
We consider how genes distinguish two types t1, t2 ∈ T from each other. For each gene g ∈ Gt we
consider its expression levels in the training samples. We rank all the training samples in terms of the
expression level of g. We are looking for genes that for high levels give type t1 and for low levels give
type t2 (or vice-versa). When ranked this way, they sometimes will perfectly separate, that is the first
part of the list is one type, and the last part is the other. These genes are ranked the highest. Most of
the time however, a gene will not separate so clearly and there will be overlapping regions. Those with
more overlaps of different types are ranked lower. In this way we have a ranking of the genes that are
best able to distinguish t1 from t2, and we pick the top M genes.
We then consider all distinct combinations of t1 and t2 and pick the best M genes from each com-
bination. Genes may overlap, narrowing the initial pool. This is our initial set of genes Gi that we will
consider.
Statistical Replication
In analogy with statistical mechanics, we can think of the scoring function as (negative) energy and
invent a dynamics that evolves them towards the highest scoring (lowest energy) states. We do this
at finite temperature to allow the system to accept predictors that occasionally may be less fit than
their predecessors to get rid of local minima in predictor space and to allow for a diverse population of
predictors.
Suppose the system has evolved to an ensemble of n gene subspaces E ≡ {G1, G2, . . . , Gn}, we will now
employ a variant of a replication algorithm used in other contexts(Ceperley & Kalos, 1979) to replicate
and modify each of the Gi’s.
1. For each G ∈ E we produce a new subspace as follows.
(a) A set of genes G has genes {g1, g2, . . . , gm}. We randomly choose a gene gr from the initial set
Gi, and add it to G, producing a new set G
′ of genes {g1, g2, . . . , gm, gr}. If gr ∈ G, G
′ = G.
(b) We compute the difference in the scoring functions δS = SG′ − SG.
6(c) We compute the weight for G′, w = exp(βδS), where β is the inverse “temperature”.
2. Let Z denote the sum of these weights. We normalize the weights by multiplying them by n/Z.
3. We replicate all subspaces according to their weights. With a weight w, the subspace is replicated
[w] and an additional time with probability w − [w]. Here [w] denotes the largest integer < w.
In summary, every subspace in the system is mutated and replicated in accordance with how much
fitter it was than its predecessor. By carefully normalizing the system, the number of subspaces in the
ensemble stays close to m. Note that we can also do more than one potential mutation in step 1. We
will generalize this to allow nm potential mutations.
Annealing
As the system evolves, the scoring function gives similar answers for all members of the ensemble. In
order to improve convergence, it is useful to make the temperature a function of the spread in scores
(or energy). A variety of schedules for the temperature were tested. We have found that good results
are obtained if β is taken to be 2/∆E, where ∆E is the maximum spread in scores between different
members of the ensemble.
This is particularly useful because the scoring function has two basic components. The first adds
unity every time a sample is correctly classified. The second adds a much smaller number proportional
to the constant C defined above, which is chosen to make this second component ≪ 1. The second
component tries to maximize the separation between the different classes. When the predictors have a
evolved so that they are all classifying correctly, we would like the second part to take effect. By lowering
the temperature by a schedule such as the one above, the algorithm will then select for predictors that
maximize the second part of the scoring function. This leads to a much better set of genes.
Deterministic Evolution
As an alternative to the statistical replication method above, we also employed a method that is com-
putationally more expensive but that often performs better. The statistical method does not explore all
possible combinations of genes at each stage of growth. This can miss optimal gene combinations. We
get around this by a deterministic exploration of the optimum gene combinations at every step. A single
step goes as follows:
1. Construct all distinct unions of the G’s in the ensemble E with individual genes in the initial gene
pool Gi, i.e. g1, g2, . . . , gm, gi.
2. Sort all of these combinations by their score, keeping the top ntop of them.
To save computer time we tried various values for ntop. It was found that ntop = n, (the number of
G’s in the ensemble) performed quite well. Another variant was to construct only half the unions and
keep the top n, for computational efficiency.
7Results
We now discuss application of the above algorithm to two data sets. The work on the small round blue
cell tumors (SRBCT) of childhood and the work on human acute leukemia(Golub et al., 1999).
SRBCT Data
Small round blue cell tumors (SRBCT) of childhood are hard to classify by current clinical techniques.
They appear similar under a light microscope and several techniques are normally needed to obtain an
accurate diagnosis. The paper (Khan et al., 2001) used microarrays to study their classification using
of a single layer neural network. This work differed from previous studies in that they were attempting
to distinguish between four different cancer types instead of the more usual 2. They used 63 samples
for training and tested with 20. By using a clever method combining principle component analysis and
sensitivity of their neural network to a gene, they were able to reduce the number genes needed to 96
yet still classify all different forms of cancer in test data perfectly.
Here we use the same data set to reduce the number of genes needed and still classify the test data
perfectly.
Starting with their data set of 2308 genes, we constructed the initial pool of genes by considering how
well a gene discriminates type i cancer from type j, as described above. Since there are 4 possible types,
we have 6 combinations of i and j. For each of these we take the top 10 genes best able to discriminate
for each i, j pair. This gives a total of 50 genes, because it turns out that 10 of these overlap between
groups.
We then evolve these gene subspaces according to the statistical replication method described above.
Fig. 1 shows the average number of genes in a predictor as a function of the number of generations.
The average is over the ensemble of predictors. It starts to level off significantly at the 38th generation,
because the addition of further genes does not improve the scoring. Fig. 2 shows how as a function
of the average number of genes, the predictors fair with the test data of 20 samples. The vertical axis
is the average number of incorrect assignments, again averaged over all predictors in the ensemble. By
the 26th generation, more than 90% of predictors perform perfectly with the test data, and by the 41st
generation, all predictors perform perfectly using an average of 28 genes.
We next use the deterministic evolution method described above only constructing half the unions.
Fig. 3 shows the average number of genes in a predictor as a function of the number of generations. In
this case it plateaus off sooner, after about 15 generations. The comparison with the test data is shown
in Fig. 4. Here all predictors perform perfectly when the average number of genes in a predictor is 15.1.
Here we only used half the possible unions and kept ntop = 50.
Encouraged by the above results we did a larger run starting with an initial pool of 90 genes of which
15 overlapped, giving a total of 75 initial genes. Evolving these with ntop = 150 gives the results shown
in fig. 5. Of the top 100 predictors, all predicted the test data perfectly. The average number of genes
8in a predictor was 12.7.
With this data, GESSES can be used to give an ensemble of predictors that have perfect or near
perfect performance. However if the initial gene pool is reduced to below 60 genes, it degrades. For
example, starting with the top 48 genes (giving 41 distinct genes) with ntop = 41 leads to a set of
predictors that make an average of 0.439 mistakes, and an average number of genes of 11.24. Despite
this, one should keep in mind that over half the predictors predict the test data perfectly. But starting
with only the top 24 genes (20 distinct genes) with ntop = 20 leads to a set of predictors that make an
average of 1.45 mistakes, and an average number of genes of 10.95.
The genes found by these methods are mostly a subset of those found previously(Khan et al., 2001).
For example with 75 initial genes as described above (fig. 5), the union of all predictor genes found in the
top 100 predictors gave a total of 24 genes. These were a subset of the 96 Khan et. al. genes. These are
shown in Table 1, (excluding three genes that occur only once among all the predictors). However with
the data of fig. 2, we find that out of a total of 25 different genes that comprise all the possible genes used
by the 50 predictors, four are different than those found by Khan et. al. Of those four, one of them appear
only once , and two of them occur quite frequently in the predictors. One, neurofibromin 2 appears in
all predictors, and the other thioredoxin appears in 37 of the 50 predictors. The third, homeobox B7
appears 6 times. Neurofibromin has been associated with tumorigenesis(Reed & Gutmann, 2001). It is
believed that thioredoxin may play a role in cancer and Thioredoxin-1 is often associated with aggressive
tumor growth(G.Powis & Montfort, 2001). In a study on multiple carcinigenesis of mouse skin(Chang
et al., 1998), Homeobox B7 appears to be expressed at a much lower level than in normal mouse skin.
Because this gene only appears in 16% of predictors, this may not be a significant correlation.
Leukemia Data
Microarray data was obtained from patients having two types of leukemia, acute lymphoblastic leukemia
(ALL), and acute myeloid leukemia (AML). The data here was taken from bone marrow samples and the
samples were of different cell types, for example B or T cells and different patient genders. Each sample
was analyzed using an Affymetrix microarrays containing expression levels of 7129 genes. The data was
divided into 38 training data points and 34 test points.
Using the statistical replication algorithm we evolved the predictors and measured the averaged
number of misclassifications made as a function of the number of generations. This is done with an
initial pool of 50 genes and the resulsts are shown in fig. (6). The number of mistakes made by the
ensemble of predictors plateaus at about 2. The predictors vary in accuracy; there are predictors that
make no mistakes and some that make several. There appears to be no way of distinguishing between
them short of using the test data. Data with 200 genes, fig. (7), shows a similar pattern but does not
completely plateau fluctuating in the average number of mistakes from about 1 to three.
On the other hand using the deterministic evolution algorithm, we find a much faster convergence
9to a steady state ensemble of predictors. Using an initial gene pool of 50 and ntop of 100, the number
of mistakes goes to about 2 with only three genes in a predictor. This is shown in fig. (8). The lack
of convergence to near perfect predictors is in agreement with other work on this data set(Furey et al.,
2000; Li & Yang, 2001; Golub et al., 1999).
Varying parameters such as the initial number of genes, ntop, and the method of scoring does not
lead to a statistically significant improvement in the average number of mistakes made. Also, as the
above cases illustrate, the optimum number of genes in a predictors varies between 3 to 25 depending on
parameters. This is consistent with recent work on this data where also no clear cutoff in the number of
genes needed for an optimal predictor was also found(Li & Yang, 2001).
Discussion
This paper has described a new and highly effective method, GESSES, that reduces the number of genes
necessary to perform an accurate classification. We implemented and tested it, producing an ensemble of
predictors that use a minimal number of genes to perform a diagnosis of a cancer from microarray data.
There are many different kinds of prediction algorithms that can be used besides the nearest neighbor
algorithm that we chose, among them are artificial neural networks, logistic regression, support vector
machines which appear to perform similarly.
We have used a nearest neighbor search method for a variety of reasons. It will classify training
points perfectly. It makes little in the way of assumptions of how new data extrapolates from old data.
And in conjunction with the replication algorithms used here it is quite efficient because it “learns”
rapidly. However which kind of predictor that is used is not the most important part of this work and
the replication algorithm could be implemented with anyone of the prediction methods mentioned above.
The main point is that evolutionary algorithms can be used to determine minimal gene sets for tissue
classification. By starting off with an initial pool of candidate genes, an ensemble of predictors is evolved
on training data. Each predictor uses a different set of genes and its fitness is scored by analyzing
how well it separates the training data into separate classes. The system evolves converging to a set of
predictors that can be evaluated using test data.
In the case of SRBCT data(Khan et al., 2001), this method was able to find predictors using fewer
than 15 genes that were able to reliably classify test data into one of four groups. Some of the genes
found were different than the 96 found earlier(Khan et al., 2001) to do this classification and may be of
biological significant. The optimum number of genes to use in a predictor is approximately 12± 2.
In the case of leukemia data(Golub et al., 1999), less useful information can be obtained. It is probably
not possible to use the training data to reliably construct a perfect predictor. It is clear that more data
is needed before the same level of prediction can be achieved as with the SRBCT data. This is in accord
with other groups findings(Golub et al., 1999; Furey et al., 2000; Li & Yang, 2001). At this point it is
not possible to come up with the optimal number of genes needed to predict this data(Li & Yang, 2001).
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The main conclusion that one draws from this is that there are many relevant genes in the diagnosis of
cancers. However if the data is not complete or is too noisy, it is not possible to exploit this information
to its full capacity.
It is hoped that using such a small set of genes could help lead to practical uses of gene expression
levels in cancer diagnosis, as it might turn out to be more practical to build devices containing only 15
oligonucleotides rather than thousands. It also might help to further the understanding of how the genes
found relate to the biology of these cancers.
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Figure 1: The average number of genes for an ensemble of predictors as a function of the number of generations,
for SRBCT data(Khan et al., 2001). The number of genes used here was 50, and the algorithm used was a statistical
replication algorithm (nm = 2).
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Figure 2: The average number of mistakes made as a function of the average number of genes in a predictor for the
same parameters as in fig. 1.
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Figure 3: The average number of genes for an ensemble of predictors as a function of the number of generations for
SRBCT data(Khan et al., 2001). The number of genes used here was 50, and the algorithm used was deterministic
described in the text.
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Figure 4: The average number of mistakes made as a function of the average number of genes in a predictor for the
same parameters as in fig. 3.
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Figure 5: The average number of mistakes made as a function of the average number of genes in a predictor for an
initial pool of 75 genes SRBCT data(Khan et al., 2001). The parameters are described in the text.
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Figure 6: The average number of mistakes for an ensemble of predictors as a function of the average number of
genes, for the leukemia data(Golub et al., 1999). The number of genes used here was 50, and the algorithm used was
a statistical replication algorithm (nm = 2). Note the curve is not singled valued because as the predictor evolves,
the average number of genes and number of mistakes can increase due to statistical fluctuations.
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Figure 7: The average number of mistakes for an ensemble of predictors as a function of the average number of
genes, for the leukemia data(Golub et al., 1999). The number of genes used here was 200, and the algorithm used
was a statistical replication algorithm (nm = 2).
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Figure 8: The average number of mistakes for an ensemble of predictors as a function of the average number of
genes, for the leukemia data(Golub et al., 1999). The number of genes used here was 200, and the algorithm used
was a deterministic algorithm.
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id# gene description
365826 growth arrest-specific 1
298062 ”troponin T2, cardiac”
383188 recoverin
296448 insulin-like growth factor 2 (somatomedin A)
769959 ”collagen, type IV, alpha 2”
377461 ”caveolin 1, caveolae protein, 22kD”
325182 ”cadherin 2, N-cadherin (neuronal)”
1473131 ”transducin-like enhancer of split 2, homolog of Drosophila E(sp1)”
207274 Human DNA for insulin-like growth factor II (IGF-2); exon 7 and additional ORF
357031 ”tumor necrosis factor, alpha-induced protein 6”
812105 transmembrane protein
241412 E74-like factor 1 (ets domain transcription factor)
183337 ”major histocompatibility complex, class II, DM alpha”
796258 ”sarcoglycan, alpha (50kD dystrophin-associated glycoprotein)”
866702 ”protein tyrosine phosphatase, non-receptor type 13 (APO-1/CD95 (Fas)-associated phosphatase)”
770394 ”Fc fragment of IgG, receptor, transporter, alpha”
52076 olfactomedinrelated ER localized protein
609663 ”protein kinase, cAMP-dependent, regulatory, type II, beta”
814260 follicular lymphoma variant translocation 1
784224 fibroblast growth factor receptor 4
295985 ESTs
Table 1: Genes found that perfectly predict SRBCT samples
